These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug design. Bohacek RS; McMartin C J Med Chem; 1992 May; 35(10):1671-84. PubMed ID: 1588550 [TBL] [Abstract][Full Text] [Related]
6. Computer design of bioactive molecules: a method for receptor-based de novo ligand design. Moon JB; Howe WJ Proteins; 1991; 11(4):314-28. PubMed ID: 1758885 [TBL] [Abstract][Full Text] [Related]
7. Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes. Bauer MR; Mackey MD J Med Chem; 2019 Mar; 62(6):3036-3050. PubMed ID: 30807144 [TBL] [Abstract][Full Text] [Related]
8. IVGA3D: De novo ligand design using a variable sized tree representation. Bandyopadhyay S; Sengupta S Protein Pept Lett; 2010 Dec; 17(12):1495-516. PubMed ID: 20518735 [TBL] [Abstract][Full Text] [Related]
9. Biomimetic recognition and immunochemical assay of ligand binding to collagen. Vaidyanathan J; Chinnaswamy K; Vaidyanathan TK J Adhes Dent; 2003; 5(1):7-17. PubMed ID: 12729079 [TBL] [Abstract][Full Text] [Related]
10. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease. Sham YY; Chu ZT; Tao H; Warshel A Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821 [TBL] [Abstract][Full Text] [Related]
11. Investigation of atomic level patterns in protein--small ligand interactions. Chen K; Kurgan L PLoS One; 2009; 4(2):e4473. PubMed ID: 19221587 [TBL] [Abstract][Full Text] [Related]
12. A fast and efficient method to generate biologically relevant conformations. Klebe G; Mietzner T J Comput Aided Mol Des; 1994 Oct; 8(5):583-606. PubMed ID: 7876902 [TBL] [Abstract][Full Text] [Related]
13. Structural basis for the resilience of Darunavir (TMC114) resistance major flap mutations of HIV-1 protease. Purohit R; Sethumadhavan R Interdiscip Sci; 2009 Dec; 1(4):320-8. PubMed ID: 20640812 [TBL] [Abstract][Full Text] [Related]
14. Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design. Zauhar RJ; Moyna G; Tian L; Li Z; Welsh WJ J Med Chem; 2003 Dec; 46(26):5674-90. PubMed ID: 14667221 [TBL] [Abstract][Full Text] [Related]